3-Methylcytidine is a urinary nucleoside that can be used as a biomarker for four different types of cancer: lung cancer, gastric cancer, colon cancer, and breast cancer. In vitro, 3-Methylcytidine is significantly upregulated in the urine samples of breast cancer patients. It is intended for research use only.
- Can be used as a biomarker for lung cancer
- Can be used as a biomarker for gastric cancer
- Can be used as a biomarker for colon cancer
- Can be used as a biomarker for breast cancer
- Significantly upregulated in urine samples of breast cancer patients
- Intended for research use only